Skip to content

13F-HR filed by Atlas Venture Life Science Advisors, LLC

Atlas Venture Life Science Advisors, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 13 holding rows worth $521,764,233.

Accession
0001104659-25-048527
Filed
2025-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 13 entries on the cover page, a total value of $521,764,233 stated on the cover page (in dollars after the unit check, H1), rows summing to $521,764,233 with VALUE read as dollars as filed, 13F file number 028-22531. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KYMERA THERAPEUTICS INC501575104COM4,896,462$134,016,165dollars as filed
DISC MEDICINE INC COM254604101Stock2,384,456$118,364,396dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock9,130,465$95,504,664dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock6,430,257$50,991,937dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK3,694,020$38,639,449dollars as filed
THIRD HARMONIC BIO INC88427A107COM10,402,286$36,095,932dollars as filed
KORRO BIO INC500946108COMMON STOCK1,137,149$19,797,764dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM5,836,874$10,389,636dollars as filed
IKENA ONCOLOGY INC45175G108COM5,018,178$6,423,269dollars as filed
AEROVATE THERAPEUTICS INC008064107COM1,799,232$4,516,072dollars as filed
Q32 BIO INC746964105Common Stock2,092,106$3,451,975dollars as filed
GENERATION BIO CO37148K100COM8,279,484$3,353,190dollars as filed
SPERO THERAPEUTICS INC84833T103COM305,255$219,784dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-048527this filing2025-05-14acceptance time not in the bulk data set